MRVI - Company ID 0001823239
The table below shows MARAVAI LIFESCIENCES HOLDINGS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $65.84M | $41.63M | $47.40M | $46.85M | $69.03M | $69.42M |
| Cost of revenue | $32.14M | $35.98M | $39.63M | $39.13M | $36.79M | $38.58M |
| Gross profit | $33.70M | $5.66M | - | $7.72M | $32.23M | - |
| R&D | $3.89M | $3.84M | $4.88M | $4.89M | $4.70M | $4.92M |
MARAVAI LIFESCIENCES HOLDINGS, INC. reported annual revenue of $185.74M for fiscal year 2025. That is down 28.3% from $259.19M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $143.14M (FY 2019) to $185.74M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $29.09M | $35.40M | $38.58M | $39.56M | $39.09M | $40.56M |
| Operating income | -$2.16M | -$41.03M | -$66.28M | -$49.16M | -$165.61M | -$13.44M |
| Income tax | -$151.00K | -$92.00K | -$4.29M | $162.00K | $311.00K | -$2.44M |
| Net income | -$3.73M | -$25.56M | -$39.59M | -$29.95M | -$97.07M | -$9.79M |
| EPS (diluted) | -$0.02 | -$0.18 | -$0.27 | -$0.21 | -$0.68 | -$0.07 |